Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Clinical Therapeutics
|
October 29, 2017
Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point
Jun Gong, Daniel Wu, Jeremy Chuang, et al.
Frontiers in Immunology
|
December 24, 2025
Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma
Pin-Jung Chen, Suzanne Devkota, Stephen Shiao, et al.
Advances in Radiation Oncology
|
November 5, 2019
18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
John M David, Yong Yue, Kevin Blas, et al.
Cancers
|
April 30, 2021
Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
Patrick C Lee, Andrew Hendifar, Arsen Osipov, et al.
The American Surgeon
|
February 3, 2018
Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors
Nicholas Manguso, Jeffrey Johnson, Attiya Harit, et al.
Clinical and Translational Medicine
|
March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Jun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.
The Oncologist
|
June 23, 2019
Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer
Elad Neeman, Gillian Gresham, Navasard Ovasapians, et al.
The American Surgeon
|
February 13, 2019
Long-Term Outcomes after Elective <i>versus</i> Emergency Surgery for Small Bowel Neuroendocrine Tumors
Nicholas Manguso, Alexandra Gangi, Nicholas Nissen, et al.
Advances in Radiation Oncology
|
April 24, 2019
Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
John M David, Sungjin Kim, Veronica R Placencio-Hickok, et al.
BMC Cancer
|
March 19, 2013
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
Sant P Chawla, Arthur Staddon, Andrew Hendifar, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Clinical Therapeutics
|
October 29, 2017
Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point
Jun Gong, Daniel Wu, Jeremy Chuang, et al.
Frontiers in Immunology
|
December 24, 2025
Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma
Pin-Jung Chen, Suzanne Devkota, Stephen Shiao, et al.
Advances in Radiation Oncology
|
November 5, 2019
18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
John M David, Yong Yue, Kevin Blas, et al.
Cancers
|
April 30, 2021
Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
Patrick C Lee, Andrew Hendifar, Arsen Osipov, et al.
The American Surgeon
|
February 3, 2018
Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors
Nicholas Manguso, Jeffrey Johnson, Attiya Harit, et al.
Clinical and Translational Medicine
|
March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Jun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.
The Oncologist
|
June 23, 2019
Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer
Elad Neeman, Gillian Gresham, Navasard Ovasapians, et al.
The American Surgeon
|
February 13, 2019
Long-Term Outcomes after Elective <i>versus</i> Emergency Surgery for Small Bowel Neuroendocrine Tumors
Nicholas Manguso, Alexandra Gangi, Nicholas Nissen, et al.
Advances in Radiation Oncology
|
April 24, 2019
Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
John M David, Sungjin Kim, Veronica R Placencio-Hickok, et al.
BMC Cancer
|
March 19, 2013
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
Sant P Chawla, Arthur Staddon, Andrew Hendifar, et al.
Page
of 9